Liu Wenying.Classifications and clinical managements of vascular abnormalities[J].Journal of Clinical Pediatric Surgery,,18():621-625.[doi:10.3969/j.issn.1671-6353.2019.08.001]
Click Copy

Classifications and clinical managements of vascular abnormalities

References:

1 Esposito F,Ferrara D,Di Serafino MA,et al.Classification and ultrasound findings of vascular anomalies in pediatric age:the essential[J].J Ultrasound,2019,22(1):13-25.DOI:10.1007/s40477-018-0342-1.
2 Mulliken JB,Glowacki J.Hemangiomas and vascular malformations in infants and children:a classification based on endothelial characteristics[J].Plast Reconstr Surg,1982,69(3):412-422.
3 Taghinia AH,Upton J.Vascular anomalies[J].J Hand Surg Am,2018,43(12):1113-1121.DOI:10.1016/j.jhsa.2018.03.046.
4 Jackson IT,Carreño R,Potparic Z,et al.Hemangiomas,vascular malformations,and lymphovenous malformations:classification and methods of treatment[J].Plast Reconstr Surg,1993,91(7):1216-1230.
5 Waner M,Suen JY.Management of congenital vascular lesions of the head and neck[J].Oncology (Williston Park),1995,9(10):989-994.
6 Powell J.Update on hemangiomas and vascular malformations[J].Curr Opin Pediatr,1999,11(5):457-463.
7 Dasgupta R,Fishman SJ.ISSVA classification[J].Semin Pediatr Surg,2014,23(4):158-161.DOI:10.1053/j.sempedsurg.2014.06.016.
8 International society for the study of vascular anomalies.ISSVA classification for Vascular Anomalies[EB/OL] [2019-08-06].http://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf.
9 Sandbank S,Molho-Pessach V,Farkas A,et al.Oral and topical sirolimus for vascular anomalies:a multicentre study and review[J],2019.DOI:10.2340/00015555-3262.[Epub ahead of print]
10 Léauté-Labrèze C,Harper JI,Hoeger PH.Infantile haemangioma[J].Lancet,2017,390 (10089):85-94.DOI:10.1016/S0140-6736(16)00645-0.
11 Gupta A,Verma A,Dhua A,et al.Vascular anomalies:a pediatric surgeon’s perspective[J].Indian J Pediatr,2017,84(8):612-617.DOI:10.1007/s12098-017-2355-8.
12 Orlow SJ,Isakoff MS,Blei F.Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution[J].J Pediatr,1997,131(4):643-646.
13 Bota M,Popa G,Blag C,et al.Infantile hemangioma:a brief review[J].Clujul medical,2015,88(1):23-27.DOI:10.15386/cjmed-381.
14 Léauté-Labrèze C,Dumas De La Roque E,Hubiche T,et al.Propranolol for severe hemangiomas of infancy[J].N Engl J Med,2008,358(24):2649-2651.DOI:10.1056/NEJMc0708819.
15 Nassiri N,Thomas J,Cirillo-Penn NC.Evaluation and management of peripheral venous and lymphatic malformations[J].J Vasc Surg Venous Lymphat Disord,2016,4(2):257-265.DOI:10.1016/j.jvsv.2015.09.001.
16 Kennedy TL,Whitaker M,Pellitteri P,et al.Cystic hygroma/lymphangioma:A rational approach to management[J].Laryngoscope,2001,111(11,pt 1):1929-1937.DOI:10.1097/00005537-200111000-00011.
17 Coffin CM,Dehner LP.Vascular tumors in children and adolescents:a clinicopathologic study of 228 tumors in 222 patients[J].Pathol Annu,1993,28 Pt 1:97-120.
18 Swetman GL,Berk DR,Vasanawala SS,et al.Sildenafil for severe lymphatic malformations[J].N Engl J Med,2012,366(4):384-386.DOI:10.1056/NEJMc1112482.
19 Leaute-Labreze C,Hoeger P,Mazereeuw-Hautier J,et al.A randomized,controlled trial of oral propranolol in infantile hemangioma[J].N Engl J Med,2015,372(8):735-746.DOI:10.1056/NEJMoa1404710.
20 Siegfried EC,Keenan WJ,Al-Jureidini S.More on propranolol for hemangiomas of infancy[J].N Engl J Med,2008,359(26):2846.DOI:10.1056/NEJMc086443.
21 Legiehn GM,Heran MK.Venous malformations:Classification,development,diagnosis,and interventional radiologic management[J].Radiol Clin North Am,2008,46(3):545.DOI:10.1016/j.rcl.2008.02.008.DOI:10.1016/j.rcl.2008.02.008.
22 Richter GT,Braswell L.Management of venous malformations[J].Facial Plast Surg,2012,28(6):603-610.

Memo

收稿日期:2019-07-19。
基金项目:国家自然科学基金(编号:81401606);四川大学优秀青年学者基金(编号:2015SU04A15)

Last Update: 1900-01-01